Figure 3From: Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiationPathologic complete response to neoadjuvant chemotherapy results in improved outcomes in Stage IV IBC patients after PMRT. (A) overall survival (B) progression-free survival.Back to article page